Recent reports have shown that activated ErbB receptors can form heterodimers with other receptor tyrosine kinases such as IGF receptors, PDGF receptors, and c-Met, and promote breast cancer cell growth and survival [40,41]. This evidence concerns the gene NTRK1 and breast carcinoma.